Abnormal placentation and placental ischemia trigger the release of anti-angiogenic factors such as soluble FMS-like tyrosine kinase-1 (sFLT-1) and soluble endoglin, leading to endothelial dysfunction and platelet activation. Here, FLT1 is linked to endothelial dysfunction.